LacriJet® is FCI latest and exclusive preloaded and self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration.

Download

Date

December 28, 2020

File Size & Type

826.42 KB PDF

Categories